| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/16/2001 | CA2223404C Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt |
| 01/16/2001 | CA2062933C Novel process for the preparation of 9-deoxo-9(z)-hydroxyiminoerythromycin a |
| 01/11/2001 | WO2001002607A1 Adenovirus carrying gag gene hiv vaccine |
| 01/11/2001 | WO2001002593A2 Control of gene expression in eukaryotic cells |
| 01/11/2001 | WO2001002587A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/11/2001 | WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002567A1 16405 receptor, a g-protein coupled receptor |
| 01/11/2001 | WO2001002559A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 01/11/2001 | WO2001002551A2 Virus like particles, preparation and use in screening and functional genomics |
| 01/11/2001 | WO2001002550A2 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | WO2001002427A1 Streptogramin derivatives, preparation and compositions containing them |
| 01/11/2001 | WO2001002414A1 Diphosphate salt of a 4''-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition |
| 01/11/2001 | WO2001002412A1 5-nitrofurfural derivatives |
| 01/11/2001 | WO2001002411A1 SULFONAMIDOMETHYL PHOSPHONATE INHIBITORS OF β-LACTAMASE |
| 01/11/2001 | WO2001002401A1 Crystalline 1-methylcarbapenem compounds |
| 01/11/2001 | WO2001002396A1 Novel benzo[f]naphthyridine, preparation and compositions containing them |
| 01/11/2001 | WO2001002390A1 Quinolinecarboxylic acid derivative or salts thereof |
| 01/11/2001 | WO2001002388A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | WO2001002387A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002365A1 Ciprofloxacin hydrates and method for their production |
| 01/11/2001 | WO2001002024A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 01/11/2001 | WO2001002018A2 Compounds that associate on the intermolecular level and aggregate bodies that contain them |
| 01/11/2001 | WO2001002017A2 Erythropoietin conjugates with polyethylenglycol |
| 01/11/2001 | WO2001002002A1 Stabilized pharmaceutical composition in lyophilized form |
| 01/11/2001 | WO2001001988A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | WO2001001985A1 Antiviral therapy |
| 01/11/2001 | WO2001001978A1 Medicinal compositions for preventing or treating viral myocarditis |
| 01/11/2001 | WO2001001963A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001962A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001959A1 Ophthalmic compositions in form of aqueous gels |
| 01/11/2001 | WO2001001958A1 Delivery system for oral care compositions comprising organosiloxane reins using a removable backing strip |
| 01/11/2001 | WO2001001940A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 01/11/2001 | WO2001001939A1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 01/11/2001 | WO2000066739A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 01/11/2001 | WO2000066604A3 L-ribo-lna analogues |
| 01/11/2001 | WO2000063364A3 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 01/11/2001 | WO2000062802A3 Vaccine comprising rsv antigen and cpg oligonucleotide |
| 01/11/2001 | WO2000062801A3 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 01/11/2001 | WO2000062800A3 Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide |
| 01/11/2001 | WO2000062657A3 Improvement of t cell mediated immunity |
| 01/11/2001 | WO2000061793A3 Novel method for identifying antibacterial compounds |
| 01/11/2001 | WO2000061189A3 Water-soluble compositions of bioactive lipophilic compounds |
| 01/11/2001 | WO2000059904A3 Compounds and methods to treat cardiac failure and other disorders |
| 01/11/2001 | WO2000059515A3 Immunomodulating polymers |
| 01/11/2001 | WO2000058466A3 Protease resistant flint analogs |
| 01/11/2001 | WO2000057868A3 Use of carbamamic acid derivatives for the treatment of viral infections |
| 01/11/2001 | WO2000054729A3 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/11/2001 | WO2000053169A8 Method of inhibiting a chaperone protein |
| 01/11/2001 | WO2000050075A3 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs |
| 01/11/2001 | WO2000046251A3 Human polyclonal antibodies from transgenic nonhuman animals |
| 01/11/2001 | WO2000037679A3 Method for determining the susceptibility to developing sepsis and therapeutics for the treatment of sepsis |
| 01/11/2001 | WO2000032226B1 Xenograft animal model for the induction of papillomas, the production of papillomavirus and the propagation thereof |
| 01/11/2001 | WO2000029551B1 Cells, culture methods, and their use in autologous transplantation therapy |
| 01/11/2001 | DE19932315A1 Benzoylpyridazine Benzoylpyridazine |
| 01/11/2001 | DE19930177A1 Intermolekular assoziierende Verbindungen und diese umfassende Aggregate Inter-molecular compounds and associating this comprehensive aggregates |
| 01/11/2001 | CA2380875A1 Cell death related drug targets in yeast and fungi |
| 01/11/2001 | CA2378539A1 Adenovirus carrying gag gene hiv vaccine |
| 01/11/2001 | CA2378116A1 Human immune response molecules |
| 01/11/2001 | CA2377932A1 Control of gene expression in eukaryotic cells |
| 01/11/2001 | CA2377780A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 01/11/2001 | CA2376698A1 Streptogramin derivatives, preparation and compositions containing them |
| 01/11/2001 | CA2376657A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 01/11/2001 | CA2376513A1 An interleukin-1 receptor antagonist and uses thereof |
| 01/11/2001 | CA2375748A1 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 01/11/2001 | CA2375157A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | CA2373882A1 Compounds having cytokine inhibitory activity |
| 01/11/2001 | CA2373879A1 Antiviral therapy |
| 01/11/2001 | CA2372935A1 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 01/10/2001 | EP1067179A1 Method to select attenuated paramyxoviridae useful for vaccines and therapeutics |
| 01/10/2001 | EP1066834A2 Pharmaceutical compositions comprising a phagocyte-modulating agent |
| 01/10/2001 | EP1066833A2 Cryopreserved cells, system for supplying cells on commission, and preventive or remedial method of infections or cancers |
| 01/10/2001 | EP1066378A2 Lyst protein complexes and lyst interacting proteins |
| 01/10/2001 | EP1066376A1 Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines |
| 01/10/2001 | EP1066321A2 Formulation having a papilloma virus-specific protein, and the production and use thereof |
| 01/10/2001 | EP1066276A1 Process for the synthesis of hiv protease inhibitors |
| 01/10/2001 | EP1066247A1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 01/10/2001 | EP1066059A1 Formulations for protection of peg-interferon alpha conjugates |
| 01/10/2001 | EP1066055A1 Adjuvant-containing vaccines |
| 01/10/2001 | EP1066053A1 Hib/dtpa vaccine composition and methods of preparation |
| 01/10/2001 | EP1066050A2 Application of hsp70 proteins |
| 01/10/2001 | EP1066040A1 Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption |
| 01/10/2001 | EP1066035A2 Substituted aromatic compounds for treatment of antibiotic resistant infections |
| 01/10/2001 | EP1066025A1 Polyalkoxy copolymers as lipase inhibitors and their compositions |
| 01/10/2001 | EP1065931A1 Compositions containing a combination of a creatine compound and a second agent |
| 01/10/2001 | EP1056722A4 Bisulfate salt of hiv protease inhibitor |
| 01/10/2001 | EP0783501B1 pyrimidone derivatives with antifungal activity |
| 01/10/2001 | EP0742791B1 Macrocyclic difluorostatone derivatives useful as antiviral agents |
| 01/10/2001 | CN1279718A Fusion proteins comprising HIV-1 Tat and/or Nef proteins |
| 01/10/2001 | CN1279687A Bi-and tri-cyclic nucleoside, nucleotide and oligonucleotide analoguse |
| 01/10/2001 | CN1279683A Method for producing f-methoxy-quinoline carboxylic acids |
| 01/10/2001 | CN1279682A bicyclic kinase inhibitors |
| 01/10/2001 | CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist |
| 01/10/2001 | CN1279666A NPY antagonists |
| 01/10/2001 | CN1279241A Tetracydic fluoquinolone carboxylic acid, its preparing process and medicinal composition containing it as active component |
| 01/10/2001 | CN1279240A Tetracyclic fluoquinolone carboxylic acid, its preparing process and medicinal composition containing it as active component |
| 01/10/2001 | CN1279107A Medicine for treating AIDS and tumor and its preparing process |
| 01/10/2001 | CN1279106A Detoxicating, Stasis-dispersing, inflammation-relieving, antalgic and refreshing medicine and its preparing process |
| 01/10/2001 | CN1279069A Exterior-applied Chinese medicine for treating aftos |